Literature DB >> 8042671

Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G).

G M Pastores1, F M Santorelli, S Shanske, B D Gelb, B Fyfe, D Wolfe, J P Willner.   

Abstract

Mutation of mitochondrial (mt) DNA at nucleotide (nt) 8993 has been reported to cause neurogenic weakness, ataxia, retinitis pigmentosa (NARP), or Leigh syndrome (LS). We report a family in whom the mutation was expressed clinically as LS and hypertrophic cardiomyopathy (CMP) in a boy who presented with a history of developmental delay and hypotonia, and who had recurrent lactic acidosis. The mother's first pregnancy resulted in the birth of a stillborn female; an apparently healthy older brother had died suddenly (SIDS) at age 2 months. MtDNA analysis identified the presence of the T8993G point mutation, which was found to be heteroplasmic in the patient's skeletal muscle (90%) and fibroblasts (90%). The identical mutation was present in leukocytes (38%) isolated from the mother, but not from the father or maternal grandmother. Our findings expand the clinical phenotype of the nt 8993 mtDNA mutation to include hypertrophic cardiomyopathy and confirm its cause of LS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042671     DOI: 10.1002/ajmg.1320500310

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.

Authors:  S L White; S Shanske; J J McGill; H Mountain; M T Geraghty; S DiMauro; H H Dahl; D R Thorburn
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

3.  Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy.

Authors:  J Marin-Garcia; R Ananthakrishnan; M J Goldenthal; J J Filiano; A Perez-Atayde
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

Review 4.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

5.  De novo mutation in the mitochondrial ATP synthase subunit 6 gene (T8993G) with rapid segregation resulting in Leigh syndrome in the offspring.

Authors:  M H Tulinius; M Houshmand; N G Larsson; E Holme; A Oldfors; E Holmberg; J Wahlström
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

6.  Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene.

Authors:  C Dionisi-Vici; S Seneca; M Zeviani; G Fariello; M Rimoldi; E Bertini; L De Meirleir
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

Review 7.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 8.  Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

Review 9.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

10.  Defining the pathogenesis of the human Atp12p W94R mutation using a Saccharomyces cerevisiae yeast model.

Authors:  Ann Meulemans; Sara Seneca; Thomas Pribyl; Joel Smet; Valerie Alderweirldt; Anouk Waeytens; Willy Lissens; Rudy Van Coster; Linda De Meirleir; Jean-Paul di Rago; Domenico L Gatti; Sharon H Ackerman
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.